Antibacterial Agents TRIZ Cases

Avibactam inhibits beta-lactamase enzymes, reducing minimum inhibitory concentration of carbapenems against resistant Mycobacterium abscessus.

Electrochemical synthesis modifies chitosan functional groups to boost antimicrobial properties, resolving limited reactivity in biomedical drug delivery.

Citrate or phosphate buffers maintain lefamulin pH between 3.0 and 5.5, preventing injection site pain, erythema, and phlebitis.

Substituted fused tricyclic compounds target the JAK3 ATP binding pocket to reduce off-target adverse effects from broad immunosuppression.

Benzofuro[3,2-c]chromen-6-one compounds target DNA Gyrase B to overcome multidrug resistance in tuberculosis and MRSA strains.

Novel monocyclic fragments coupled to an aminopiperidine naphthyridine scaffold deliver high enzymatic inhibitory activity against resistant bacterial pathogens.

Novel compounds of formula I inhibit the FabI enzyme through a specific nitrogen-based heterocycloalkyl group attached to a carbonyl moiety.

Purified equine antisera neutralizes anthrax exotoxins, bypassing vaccine availability limits and antibiotic resistance issues.

Polystyrene divinyl benzene copolymer beads remove cytokines from the gut to mitigate systemic inflammation and shock.

Modifying glycosphingolipid structures with aromatic groups resolves non-specific cytokine profiles, enhancing antitumor efficacy.

Recombinant attenuated Salmonella strains express conserved antigens to stimulate potent immune responses.

Ligand-dependent transcription factors enable precise control over IL-12 and TNF-alpha expression, reducing toxicity in cancer gene therapy.

Functionalized nanoparticles trap virions using pathogen-binding receptors, enabling macrophage clearance of SARS-CoV-2 infections.

Phage strains 72APm5211, 39APmC32, and 65APm2833 degrade Proteus mirabilis biofilms to treat multidrug-resistant urinary tract infections.

Chemically attenuated Mycoplasma bovis strain overcomes delayed protection and multiple dose requirements of killed vaccines.

Palonosetron and netupitant act synergistically to resolve gender-specific treatment limitations in chronic neuropathic pain and irritable bowel syndrome.

Heat-treated cashew nut shell liquid replaces antibiotics to control Clostridium perfringens infections without causing resistance.

A monoclonal antibody binds the O25b antigen on multi-drug resistant E. coli strains with high specificity and affinity.

High ionic strength alkaline buffer autooxidizes DOPA to form adherent polymer films on diverse substrates.

Engineered antimicrobial peptides overcome resistance by modifying specific amino acid positions to balance broad-spectrum activity with solubility.

A peptide inhibits toxin-antitoxin complex formation in Mycobacterium tuberculosis by binding to specific antitoxin residues.

Novel isoquinolone derivatives target Rho-kinase mediated phosphorylation to address inadequate disease management in cardiovascular conditions.

Monoclonal antibodies target the Mac-1 I-domain to block leukocyte recruitment without impairing host defense.

Combining surfactants and solvents creates robust pellets that withstand processing while enhancing drug absorption in the GI tract.

Combines porcine circovirus type 2 and Lawsonia intracellularis antigens into a single immunogenic formulation for swine.

Administering balsalazide with food delays colonic transit time, reducing systemic 5-ASA absorption while increasing local mucosal exposure.

DVD binding proteins combine variable domains to target interleukins, avoiding mis-paired by-products from quadroma technology.

A multiepitope fusion antigen combines CFA adhesins and enterotoxins to elicit cross-reactive antibodies.

Novel phosphonic acid derivatives act as potent sphingosine-1-phosphate receptor modulators for treating inflammatory and cardiovascular disorders.

Quantifying HBP levels in cerebrospinal fluid enables rapid diagnosis of bacterial meningitis despite prior antibiotic treatment.

Formyl-substituted pyrido-imidazo rifamycins lower intestinal absorption to 15 percent, reducing systemic toxicity and microbiota disruption.

Fusing distinct MOMP peptide variants into single constructs elicits broad cross-reactive immune responses against Chlamydia trachomatis serovars.

Plant cells express TNFα inhibitors to eliminate viral contamination risks from mammalian systems.

ANGPTL4-derived peptides stabilize vascular barriers, reducing sepsis-induced dysfunction and mortality by maintaining endothelial integrity.

A hydroalcoholic antimicrobial composition uses a hydrophobic polymer to enhance skin adhesion of medical articles.

Amphiphilic cyclobutenes mimic natural fatty acid feedstocks to disrupt mycobacterial cell wall synthesis.

A feminine care pad integrates a pH-sensitive chromogen that changes color to signal antimicrobial efficacy status.

A pure ointment of lithospermum, beeswax, insect-white wax, and lard promotes tissue restoration.

Calcium channel blockers replace toxic antibiotics with immunomodulation, reducing multidrug resistance and treatment duration for HIV patients.

Pyrimidine compounds inhibit F-ATP synthase to reduce IC50 values and overcome drug resistance in MDR-TB.

Acyl-acetal linkage in prodrug compounds enables controlled release of nitric oxide and parent therapeutic agents while reducing gastrointestinal toxicity.